Olema Pharmaceuticals Inc [OLMA] stock is trading at $15.43, up 5.04%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The OLMA shares have gain 7.83% over the last week, with a monthly amount glided 39.51%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Olema Pharmaceuticals Inc [NASDAQ: OLMA] stock has seen the most recent analyst activity on April 02, 2024, when Goldman initiated its Buy rating and assigned the stock a price target of $24. Previously, Citigroup started tracking the stock with Buy rating on January 30, 2024, and set its price target to $20. On July 21, 2023, Oppenheimer initiated with a Outperform rating and assigned a price target of $21 on the stock. CapitalOne started tracking the stock assigning a Overweight rating and suggested a price target of $16 on May 05, 2023. Credit Suisse initiated its recommendation with a Outperform and recommended $12 as its price target on February 22, 2023. In a note dated June 09, 2022, H.C. Wainwright upgraded an Buy rating on this stock but restated the target price of $12.
Olema Pharmaceuticals Inc [OLMA] stock has fluctuated between $7.78 and $17.79 over the past year. Currently, Wall Street analysts expect the stock to reach $27 within the next 12 months. Olema Pharmaceuticals Inc [NASDAQ: OLMA] shares were valued at $15.43 at the most recent close of the market. An investor can expect a potential return of 74.98% based on the average OLMA price forecast.
Analyzing the OLMA fundamentals
Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -58.23%, Pretax Profit Margin comes in at -52.73%, and Net Profit Margin reading is -52.73%. To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -0.43 and Total Capital is -0.46. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.87 points at the first support level, and at 14.31 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.75, and for the 2nd resistance point, it is at 16.07.
Ratios To Look Out For
For context, Olema Pharmaceuticals Inc’s Current Ratio is 9.61. Further, the Quick Ratio stands at 9.61, while the Cash Ratio is 1.29.
Transactions by insiders
Recent insider trading involved Harmon Cyrus, Director, that happened on Jul 11 ’24 when 5000.0 shares were sold. Director, Harmon Cyrus completed a deal on Jun 28 ’24 to sell 20000.0 shares. Meanwhile, Director Graham G. Walmsley sold 1.18 million shares on Jun 04 ’24.
